De Motu Cordis (DMC) welcomed Queensland Treasurer and Minister for Trade and Investment Honourable Cameron Dick MP
April 4, 2023
On April 4, 2023, De Motu Cordis (DMC) welcomed Queensland Treasurer and Minister for Trade and Investment Honourable Cameron Dick MP to our Brisbane premises.
It was a great opportunity for our company founder Professor John Fraser to provide an update on extensive research work being conducted at the Critical Care Research Group (CCRG), for which the Minister first saw at early concept stage, while Minister for Health.
The group also spent time covering the ground-breaking global initiatives of the COVID-19 Critical Care Consortium.
The DMC team provided a tour of our facility providing an overview of our exciting technology platform from concept, through skills lab development to pilot production.
It was an absolute pleasure to have such an engaged and highly interactive senior member of Government spend time with us.
About DMC
DMC is a clinical stage medtech company founded in Brisbane, Australia by globally recognised intensive care specialist, researcher, entrepreneur and founder Professor John Fraser AO.
DMC is developing a proprietary inhaled drug delivery platform for use in critical care emergencies. Our lead asset is an investigational inhaled epinephrine product to treat anaphylaxis.
DMC has a strong suite of intellectual property portfolio protecting both its inhaled drug delivery platform and therapeutic formulations. To date, DMC has raised more than AU$30 million from both private and public sector investors.
